FDA Inspection 1263613 — Strive Pharmaceuticals, Inc.
The FDA completed an inspection of Strive Pharmaceuticals, Inc. on March 5, 2025 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2025
- Fiscal Year
- 2025
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- East Brunswick, NJ (United States)